Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability | Randa Tag

Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability

Citation:: El-Nabarawi, M. A., E. R. Bendas, R. Tag, and M. Y. S. Abary, "Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability", International Journal of Pharmaceutics, vol. 443, issue 1–2, pp. 307–317, 2013.